SCHEMBL10069400

SCHEMBL10069400

CC(=O)C(N)c1ccc2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 4/20 0.45
CYP1A2 P05177 3/20 0.45
MAPT P10636 2/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
MGAM O43451 1/20 0.44
PRNP P04156 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
RXFP1 Q9HBX9 2/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.44
MAPK10 P53779 1/20 0.43
NCF1 P14598 2/20 0.41
NOS2 P35228 1/20 0.41
BACE1 P56817 1/20 0.41
CNR2 P34972 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27721065 0.84 MGAM (0.50) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL13947088 0.81 ALDH1A1 (0.53) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL9870690 0.77 MGAM (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL29457163 0.76 CYP1A2 (0.47) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL9682782 0.76 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL30238578 0.76 NCF1 (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL20559366 0.76 NCF1 (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL28457794 0.76 NCF1 (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL3636052 0.76 NCF1 (0.48) ALDH1A1HSD17B10KDM4ECYP1A2MAPT
SCHEMBL29842330 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10KDM4ECYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021876-A2 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2012-02-16 WO disclosed